Inhibitors of HIV replication

Details for Australian Patent Application No. 2010234241 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Sturino, Claudio; Deroy, Patrick; Duplessis, Martin; Edwards, Paul J.; Faucher, Anne-Marie; Halmos, Teddy; James, Clint; Lacoste, Jean-Eric; Malenfant, Eric; Minville, Joannie; Morency, Louis; Morin, Sebastien; Tremblay, Martin; Yoakim, Christiane

Agent Spruson & Ferguson

Pub. Number AU-A-2010234241

PCT Pub. Number WO2010/115264

Priority 61/263,689 23.11.09 US; 61/168,032 09.04.09 US

Filing date 7 April 2010

Wipo publication date 14 October 2010

International Classifications

C07D 491/048 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/147 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/115264 Priority application(s): WO2010/115264

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234244-Once-daily oral IR/CR pramipexole formulation

2010234238-Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor